The Female Health Company to Present at Sidoti's Semi-Annual New York Micro-Cap
Conference
CHICAGO, Jan. 4, 2012 /PRNewswire via COMTEX/ -- The Female Health Company
(nasdaq-cm:FHCO - News), which manufactures and markets the FC2 Female Condom?,
today announced that it will be presenting at the Sidoti & Company 2012
Semi-Annual New York Micro-Cap Conference on January 9, 2012. The Conference will
be held at The Grand Hyatt in New York City.
O.B. Parrish, Chief Executive Officer, and Donna Felch, Chief Financial Officer,
will present an overview of The Female Health Company at 2:00 PM Eastern Time on
Monday, January 9, 2012 in the Estate 2 Edison room. The Company's executives
will also meet with investors to discuss the Company's ongoing operations.
About Sidoti & Company, LLC
Sidoti & Company, LLC, founded in 1999, continues to set the Wall Street standard
for independent small-cap equity research, while rapidly becoming a driving force
in micro-cap research, launching coverage of more than 100 equities of $200
million market cap or less since inception in mid-2010. Its analysts mine dozens
of industries to provide unbiased, institutional-quality research focusing on the
investment merits of profitable companies at a sub-$3 billion market cap, and it
anticipates extending coverage to 700 small-cap equities by the end of 2012.
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets
the FC2 Female Condom? (FC2), which is available in the U.S. and in about 120
other countries globally. The Company owns certain worldwide rights to the FC2
Female Condom?, including patents that have been issued in the U.S., the European
Union, Canada, Australia, South Africa, Japan, The People's Republic of China,
Spain, Mexico, Greece, Turkey and the African Regional Intellectual Property
Organization (ARIPO), which includes Botswana, The Gambia, Ghana, Kenya, Lesotho,
Malawi, Mozambique, Namibia, Sierra Leone, Somalia, Sudan, Swaziland, Uganda,
United Republic of Tanzania, Zambia and Zimbabwe. FC2 patent applications are
pending in various countries. The FC2 Female Condom? is the only available
FDA-approved product controlled by a woman that offers dual protection against
sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. The
World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies. |
